|
1
|
Lordick F and Terashima M: Gastric cancer
adjuvant therapy. Best Pract Res Clin Gastroenterol. 30:581–591.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoon H and Kim N: Diagnosis and management
of high risk group for gastric cancer. Gut Liver. 9:5–17. 2015.
View Article : Google Scholar :
|
|
3
|
Gong EJ and Kim DH: Endoscopic
ultrasonography in the diagnosis of gastric subepithelial lesions.
Clin Endosc. 49:425–433. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xue H, Ge HY, Miao LY, Wang SM, Zhao B,
Wang JR and Cui LG: Differential diagnosis of gastric cancer and
gastritis: The role of contrast-enhanced ultrasound (CEUS). Abdom
Radiol (NY). 42:802–809. 2017. View Article : Google Scholar
|
|
5
|
Bass AJ, Thorsson V, Shmulevich I,
Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C,
Shen H, et al Cancer Genome Atlas Research Network: Comprehensive
molecular characterization of gastric adenocarcinoma. Nature.
513:202–209. 2014. View Article : Google Scholar :
|
|
6
|
Badgwell B: Multimodality therapy of
localized gastric adenocarcinoma. J Natl Compr Canc Netw.
14:1321–1327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ghadyalpatil NS, Supriya C, Prachi P,
Ashwin D and Avanish S: Gastrointestinal cancers in India:
Treatment perspective. South Asian J Cancer. 5:126–136. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pasechnikov V, Chukov S, Fedorov E,
Kikuste I and Leja M: Gastric cancer: Prevention, screening and
early diagnosis. World J Gastroenterol. 20:13842–13862. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lazăr DC, Tăban S, Cornianu M, Faur A and
Goldiş A: New advances in targeted gastric cancer treatment. World
J Gastroenterol. 22:6776–6799. 2016. View Article : Google Scholar
|
|
10
|
Riquelme I, Saavedra K, Espinoza JA, Weber
H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC and Bizama C:
Molecular classification of gastric cancer: Towards a
pathway-driven targeted therapy. Oncotarget. 6:24750–24779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kothari N and Almhanna K: Current status
of novel agents in advanced gastroesophageal adenocarcinoma. J
Gastrointest Oncol. 6:60–74. 2015.PubMed/NCBI
|
|
12
|
Zhang J, Huang JY, Chen YN, Yuan F, Zhang
H, Yan FH, Wang MJ, Wang G, Su M, Lu G, et al: Erratum: Whole
genome and transcriptome sequencing of matched primary and
peritoneal metastatic gastric carcinoma. Sci Rep. 5:153092015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hudler P: Challenges of deciphering
gastric cancer heterogeneity. World J Gastroenterol.
21:10510–10527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
DeRisi JL, Iyer VR and Brown PO: Exploring
the metabolic and genetic control of gene expression on a genomic
scale. Science. 278:680–686. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Golub TR, Slonim DK, Tamayo P, Huard C,
Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri
MA, et al: Molecular classification of cancer: Class discovery and
class prediction by gene expression monitoring. Science.
286:531–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets - update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar
|
|
17
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto Encyclopedia of Genes and Genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar
|
|
18
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar
|
|
22
|
Correa P: A human model of gastric
carcinogenesis. Cancer Res. 48:3554–3560. 1988.PubMed/NCBI
|
|
23
|
Holbrook JD, Parker JS, Gallagher KT,
Halsey WS, Hughes AM, Weigman VJ, Lebowitz PF and Kumar R: Deep
sequencing of gastric carcinoma reveals somatic mutations relevant
to personalized medicine. J Transl Med. 9:1192011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lim B, Kim JH, Kim M and Kim SY: Genomic
and epigenomic heterogeneity in molecular subtypes of gastric
cancer. World J Gastroenterol. 22:1190–1201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pfeifer SP: From next-generation
resequencing reads to a high-quality variant data set. Hered Edinb.
118:111–124. 2017. View Article : Google Scholar
|
|
26
|
Raja UM, Gopal G and Rajkumar T:
Intragenic DNA methylation concomitant with repression of ATP4B and
ATP4A gene expression in gastric cancer is a potential serum
biomarker. Asian Pac J Cancer Prev. 13:5563–5568. 2012. View Article : Google Scholar
|
|
27
|
Yang M, Jiang N, Cao QW, Ma MQ and Sun Q:
The E3 ligase UBR5 regulates gastric cancer cell growth by
destabilizing the tumor suppressor GKN1. Biochem Biophys Res
Commun. 478:1624–1629. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoon JH, Choi WS, Kim O, Choi BJ, Nam SW,
Lee JY and Park WS: Gastrokine 1 inhibits gastric cancer cell
migration and invasion by downregulating RhoA expression. Gastric
Cancer. 20:274–285. 2017. View Article : Google Scholar
|
|
29
|
Kim O, Yoon JH, Choi WS, Ashktorab H,
Smoot DT, Nam SW, Lee JY and Park WS: Gastrokine 1 inhibits
gastrin-induced cell proliferation. Gastric Cancer. 19:381–391.
2016. View Article : Google Scholar
|
|
30
|
Xing R, Cui JT, Xia N and Lu YY: GKN1
inhibits cell invasion in gastric cancer by inactivating the
NF-kappaB pathway. Discov Med. 19:65–71. 2015.PubMed/NCBI
|
|
31
|
Wu W, Juan WC, Liang CR, Yeoh KG, So J and
Chung MC: S100A9, GIF and AAT as potential combinatorial biomarkers
in gastric cancer diagnosis and prognosis. Proteomics Clin Appl.
6:152–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kong Y, Zheng Y, Jia Y, Li P and Wang Y:
Decreased LIPF expression is correlated with DGKA and predicts poor
outcome of gastric cancer. Oncol Rep. 36:1852–1860. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang D, Yu X and Wang X: High/positive
expression of 5-fluorouracil metabolic enzymes predicts better
response to S-1 in patients with gastric cancer: A meta-analysis.
Int J Biol Markers. 31:e101–e109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hunt RH, Camilleri M, Crowe SE, El-Omar
EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM,
Rugge M, et al: The stomach in health and disease. Gut.
64:1650–1668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Di Mario F and Goni E: Gastric acid
secretion: Changes during a century. Best Pract Res Clin
Gastroenterol. 28:953–965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martinsen TC, Bergh K and Waldum HL:
Gastric juice: A barrier against infectious diseases. Basic Clin
Pharmacol Toxicol. 96:94–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Modlin IM, Sachs G, Wright N and Kidd M:
Edkins and a century of acid suppression. Digestion. 72:129–145.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wagner CA and Geibel JP: Acid-base
transport in the collecting duct. J Nephrol. 15(Suppl 5):
S112–S127. 2002.PubMed/NCBI
|
|
39
|
Alper SL: Genetic diseases of acid-base
transporters. Annu Rev Physiol. 64:899–923. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li JH, Han L, Du TP and Guo MJ: The effect
of low-nitrogen and low-calorie parenteral nutrition combined with
enteral nutrition on inflammatory cytokines and immune functions in
patients with gastric cancer: A double blind placebo trial. Eur Rev
Med Pharmacol Sci. 19:1345–1350. 2015.PubMed/NCBI
|
|
41
|
Ishizuka M, Oyama Y, Abe A, Tago K, Tanaka
G and Kubota K: Prognostic nutritional index is associated with
survival after total gastrectomy for patients with gastric cancer.
Anticancer Res. 34:4223–4229. 2014.PubMed/NCBI
|
|
42
|
Tegels JJ, De Maat MF, Hulsewé KW,
Hoofwijk AG and Stoot JH: Improving the outcomes in gastric cancer
surgery. World J Gastroenterol. 20:13692–13704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun K, Chen S, Xu J, Li G and He Y: The
prognostic significance of the prognostic nutritional index in
cancer: A systematic review and meta-analysis. J Cancer Res Clin
Oncol. 140:1537–1549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kang C, Song JJ, Lee J and Kim MY:
Epigenetics: An emerging player in gastric cancer. World J
Gastroenterol. 20:6433–6447. 2014. View Article : Google Scholar : PubMed/NCBI
|
